MAPT and Alzheimer disease: Measures of Aβ, tau and neurodegeneration (A/T/N) can be obtained using positron emission tomography (PET), cerebrospinal fluid (CSF) or structural magnetic resonance imaging (MRI), and are now being used to biologically define AD within a research framework [4].